GMReis reached a regulatory milestone with the FDA 510(k) clearance of its Ulna Shortening Plating System, reinforcing the company’s strategic expansion in the global upper extremity market.
Engineered to support precise and reproducible ulna shortening osteotomies, the system incorporates features such as interfragmentary compression, variable-angle locking technology, and dedicated surgical guides, enabling surgeons to enhance fixation stability and procedural efficiency.
This milestone expands GMReis’ position as a comprehensive upper limb solutions provider, with a portfolio that now spans from hand to scapula, including a wide range of plating systems and integrated solutions for soft tissue injuries associated with trauma.
GMReis reached a regulatory milestone with the FDA 510(k) clearance of its Ulna Shortening Plating System, reinforcing the company’s strategic expansion in the global upper extremity market.
Engineered to support precise and reproducible ulna shortening osteotomies, the system incorporates features such as interfragmentary compression,...
GMReis reached a regulatory milestone with the FDA 510(k) clearance of its Ulna Shortening Plating System, reinforcing the company’s strategic expansion in the global upper extremity market.
Engineered to support precise and reproducible ulna shortening osteotomies, the system incorporates features such as interfragmentary compression, variable-angle locking technology, and dedicated surgical guides, enabling surgeons to enhance fixation stability and procedural efficiency.
This milestone expands GMReis’ position as a comprehensive upper limb solutions provider, with a portfolio that now spans from hand to scapula, including a wide range of plating systems and integrated solutions for soft tissue injuries associated with trauma.
Copy to clipboard 
